Apr 02, 2020
Stem Cell Therapy for Colon Cancer
Jan 30, 2020
Cancer Stem Cells Market Expected to Generate Revenue of $ 1,722.7 Million, Growing at a CAGR of 10.3% by 2026
Sep 17, 2019
Study indicates early infusion of mononuclear cells could aid in recovery from stroke
Jun 18, 2019
The global cancer stem cell therapy market size at a CAGR of over 11% during the forecast period
Jun 11, 2019
Incubation with Extracellular Vesicles Boosts Cells' Grafting Ability
Apr 22, 2019
The global circulating tumor cells market size is anticipated to reach USD 17.56 billion by 2025 growing at a CAGR of 15.0% during the forecast period
Apr 11, 2019
Higher Oxygen Levels Could Increase Effectiveness of New Line of Brain Cancer-Killing Drugs
Feb 27, 2019
BioAtla Presents CAB-CTLA-4 And CAB-EpCAM-ADC Data At The American Association For Cancer Research Annual Meeting
Feb 05, 2019
Predictive Markers of Survival Identified for Next Generation Cancer Stem Cell Vaccine
Jan 23, 2019
Kanazawa University Research: Important Signaling Pathway in Breast Cancer Revealed
Jan 07, 2019
Stelexis Therapeutics Closes $43 million Series A to Expand Novel Platform Focused on Cancer Interception
Nov 08, 2018
The Leukemia & Lymphoma Society (LLS) Fuels the Next Generation of Cancer Research Committing More Than $188 Million in Funding
Sep 12, 2018
Propanc Biopharma Provides Shareholder Update after Presenting at the 25th Annual NewsMakers in the Biotech Industry Conference
Aug 08, 2018
Study is First on Humans to Show the Promise of Mesenchymal Stem Cells in Sepsis Therapy
Jul 31, 2018
Primary Cells Market Worth $1,107.3 Million by 2023
Jul 02, 2018
Enhancing Stem Cells With Oxygen and Forming Them Into Spheroids Leads to Better Bone Repair
May 10, 2018
Cancer Treatment Developed at Ben-Gurion University Shows Ability to Reprogram Cancer Cells to Pre-Cancerous State
Apr 09, 2018
Cancer Stem Cells Market Worth $1.6 Billion by 2025 | CAGR: 9.98%: Grand View Research, Inc.
Dec 06, 2017
Forty Seven Inc. Receives $5 Million Grant from The California Institute for Regenerative Medicine (CIRM) to Support Ongoing Clinical Trial in Acute Myeloid Leukemia
Sep 19, 2017
Anti-Chemoresistance Study on DolCas BCM-95 Shows Excellent Results